// App-Quantinova.ai

2005 : Impact of EGFR and ALK mutation on the outcomes of non-small cell lung cancer (NSCLC) patients with brain metastases.

Researchers

Presenter

  • Suresh Kumar Balasubramanian

Principal Investigators

  • Vyshak Alva Venur

  • Samuel T. Chao

  • Lilyana Angelov

  • Alireza Mohammad Mohammadi

  • Gene H. Barnett

  • Xuefei Jia

  • Manmeet Singh Ahluwalia

Medical Centers

  • Cleveland Clinic Foundation, Cleveland, OH

  • Fairview Hosp Cleveland Clinic Hospital, Cleveland, OH

  • The Cleveland Clinic, University Heights, OH

  • Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Brain metastasis

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Anaplastic lymphoma Kinase

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved